Faculty

Institution

Unit

Venue

Kumudha Balakrishnan

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Lymphoma And Myeloma

NoneKumudha Balakrishnan is currently serving as a Lymphoma And Myeloma faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kumudha Balakrishnan

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

leukemia immunology cell biology hematological malignancies pharmacology hematology oncology lymphoid neoplasia tumor biology cancer cells cancer research cell death medicine therapeutic targets apoptosis cell signaling oncogenes cancer treatment cellular therapy immune responses pharmacotherapy medicinal research enzyme inhibition cancer biology anti-cancer agents cell metabolism medicinal chemistry blood cells experimental medicine molecular cancer signaling pathways tumor targeting cellular immune responses cell therapy mitochondrial function redox biology free radical biology molecular metabolism pathway analysis cell regulation drug targeting mitophagy tissue homing oral forodesine clinical transplantation stem cell research renal pathophysiology reactive oxygen species t-regulatory cell adaptive immune system pharmaceutical chemistry chemical derivative novel therapies mechanisms of action pharmacological agents immunomodulation pediatric hematology genome instability cell cycle drug trials cord blood cancer management overcomes signals gamma inhibitor clinical-laboratory study refractory acute leukemias antitumor activity altered expression duvelisib treatment apoptotic regulators potent anticancer agents novel hydrogen peroxide pharmacodynamic study methide precursors hydrogen peroxide kinase activity

Notable Scholarly Works

Notable Federal Grants

Collaborators

Abcl-698: Evaluation of Gene Expression Assays to Classify Large B-Cell Lymphoma by Molecular Subtype From Formalin-Fixed, Paraffin-Embedded Tumor Biopsy Tissue (Ffpet). Clinical Lymphoma Myeloma & Leukemia (2025)

pathologylarge b-cell lymphomalymphoid neoplasiacancer researchoncologymolecular subtypehematological malignanciescancer discoverymolecular pathologytumor biologyimmunologygene expression assayscell biologymolecular diagnostics

A Novel Cd94-Targeting Car T Cell Therapy for Cytotoxic Subtypes of T/Nk-Cell Malignancies. Blood (2025)

cancer immunotherapycellular immune responsesimmune responsescancer cellscytotoxic subtypest/nk-cell malignanciescellular therapycell researchimmunologyimmunotherapycell therapycell biologytherapeutic targets

Epigenetically Driven Upregulation of Immunoproteasome Component Psmb8 Characterizes Diffuse Large B-Cell Lymphoma (Dlbcl) With Inflammatory Microenvironment in African Ancestry Patients. Blood (2025)

immunoproteasome component psmb8pathologylarge b-cell lymphomaimmune responsesoncogeneslymphoid neoplasiaafrican ancestry patientshematological malignanciesleukemiaimmunologyautoimmune diseasescell biologymolecular diagnosticsautoimmunity

Kir3Dl2-Directed Car T Cell Therapy for T Cell Malignancies. Blood (2025)

cancer immunotherapycellular immune responsescell transplantationt cell malignanciescellular therapyimmunotherapyimmunologycell therapycancer cells

Sasp-Driven Immune Evasion Defines a Novel African Ancestry-Associated Dlbcl Subtype With Distinctive Molecular and Immune Vulnerabilities. Blood (2025)

geneticshuman geneticsdistinctive molecularinfectious diseasesmedical virologyimmunogeneticsleukemiaimmune vulnerabilitiessasp-driven immune evasionimmunologyimmune responsesmolecular diagnosticsdisease susceptibility

Targeting B- and T-Cell Lymphomas With Anti-Cxcr5 Car T Cell Therapy. Blood (2025)

t-cell lymphomaspathologycancer immunotherapylymphoid neoplasiacell transplantationcellular therapyimmunotherapyimmunologyimmune checkpoint inhibitorscancer cells

Abstract Po-016: Test-The-Test: Clinical Utility of Comprehensive Whole Exome Sequencing (Wes) and Rna-Seq for Lymphoma Patients. Blood Cancer Discovery (2024)

geneticspathologyhuman geneticslymphoma patientsoncogeneslymphoid neoplasiacancer researchoncologynext-generation sequencingcancer genomicsleukemiaclinical utilitytranscriptomemolecular diagnostics

Comprehensive Molecular Characterization of Monomorphic Post-Transplant Lymphoproliferative Disorder (Ptld). Blood (2024)

Jean L. KoffKumudha BalakrishnanMichael ChurnetskiMichelle J. LeeAnna KurilovichSvetlana PaponovaAlexander NesmelovKsenia ZornikovaPavel ZemskiyAlexander BagaevNikita KotlovChristopher R. Flowers

molecular biologycomprehensive molecular characterizationmolecular characterization

Evaluating the Clinical Utility of Real-Time Comprehensive Whole Exome Sequencing and Rna-Seq for Patients With Diffuse Large B-Cell Lymphoma. Blood (2024)

pathologyhematologymolecular diagnosticslymphoid neoplasiaoncologyhematological malignanciesleukemiaclinical utilityimmunologytranscriptomeomics

Genomic and Spatial Proteomic Characterization of the Microenvironment of Diffuse Large B-Cell Lymphoma in African American Patients. Blood (2024)

Michelle J. LeeKumudha BalakrishnanArman PetrosyantsDaniil WiebeChijioke NzeNeha AkkadAmy AyersJames D. AyresTimothy J. McDonnellPavel ZemskiyKiril KriukovAlexander NesmelovKsenia ZornikovaKrystle NomieAlexander SarachakovNikita KotlovAnkur SinghJean L. KoffChristopher R. Flowers

cancer cellsafrican american studiesafrican american patientshematologymolecular cancercancer researchproteomicstumor heterogeneitycancer genomicsspatial proteomic characterizationgenome biologylymphoid neoplasiaoncologyclinical proteomicsimmunologyhematological malignanciestumor microenvironmentcancer discoverymolecular biologyblood cells

1
2
3
4
5
10
10 / page

Kumudha Balakrishnan

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Lymphoma And Myeloma

NoneKumudha Balakrishnan is currently serving as a Lymphoma And Myeloma faculty at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Kumudha Balakrishnan

The University of Texas MD Anderson Cancer Center

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

A Novel Cd94-Targeting Car T Cell Therapy for Cytotoxic Subtypes of T/Nk-Cell Malignancies. Blood (2025)

Kir3Dl2-Directed Car T Cell Therapy for T Cell Malignancies. Blood (2025)

cancer immunotherapycellular immune responsescell transplantationt cell malignanciescellular therapyimmunotherapyimmunologycell therapycancer cells

Sasp-Driven Immune Evasion Defines a Novel African Ancestry-Associated Dlbcl Subtype With Distinctive Molecular and Immune Vulnerabilities. Blood (2025)

Targeting B- and T-Cell Lymphomas With Anti-Cxcr5 Car T Cell Therapy. Blood (2025)

t-cell lymphomaspathologycancer immunotherapylymphoid neoplasiacell transplantationcellular therapyimmunotherapyimmunologyimmune checkpoint inhibitorscancer cells

Abstract Po-016: Test-The-Test: Clinical Utility of Comprehensive Whole Exome Sequencing (Wes) and Rna-Seq for Lymphoma Patients. Blood Cancer Discovery (2024)

geneticspathologyhuman geneticslymphoma patientsoncogeneslymphoid neoplasiacancer researchoncologynext-generation sequencingcancer genomicsleukemiaclinical utilitytranscriptomemolecular diagnostics

Comprehensive Molecular Characterization of Monomorphic Post-Transplant Lymphoproliferative Disorder (Ptld). Blood (2024)

Jean L. KoffKumudha BalakrishnanMichael ChurnetskiMichelle J. LeeAnna KurilovichSvetlana PaponovaAlexander NesmelovKsenia ZornikovaPavel ZemskiyAlexander BagaevNikita KotlovChristopher R. Flowers

molecular biologycomprehensive molecular characterizationmolecular characterization

Evaluating the Clinical Utility of Real-Time Comprehensive Whole Exome Sequencing and Rna-Seq for Patients With Diffuse Large B-Cell Lymphoma. Blood (2024)

pathologyhematologymolecular diagnosticslymphoid neoplasiaoncologyhematological malignanciesleukemiaclinical utilityimmunologytranscriptomeomics

Genomic and Spatial Proteomic Characterization of the Microenvironment of Diffuse Large B-Cell Lymphoma in African American Patients. Blood (2024)

1
2
3
4
5
10
10 / page